OPKO Health, Inc. (OPK) News
Follow OPKO Health, Inc. (OPK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 24 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
OPKO Health Swings to Q3 Net Loss of $53.5 Million as Revenue Rises 16%
OPKO Health reported Q3 revenue of $65.4 million, up 16%.
EQUITY | Nov 04, 2026, 10:26 PM UTC
M
OPKO Health Reports Third-Quarter 2026 Financial Results
EQUITY | Nov 04, 2026, 09:23 PM UTC
M
OPKO Health Sets Third-Quarter 2026 Results Report
OPKO Health says it will report third-quarter 2026 financial results.
EQUITY | Oct 28, 2026, 12:53 PM UTC
M
OPKO Health to Sell BioReference Lab Assets to Labcorp for $722 Million Plus Earnout
OPKO Health entered an asset purchase agreement to sell BioReference’s clinical and anatomic pathology lab testing assets to Labcorp for $722 million in cash at closing, subject to revenue-based adjustments, plus up to $
MNA | Oct 15, 2026, 08:14 PM UTC
M
Crude Oil Rises 2.8% to $97.77 as Stocks Trade Mixed
Oil rose 2.8% to $97.77. U.S. stocks were mixed midway through trading, with the Dow up 0.93%, the Nasdaq down 0.24% and the S&P 500 up 0.16%.
EQUITY | Oct 15, 2026, 05:22 PM UTC
M
Labcorp to Buy Opko Health Unit Assets for Up to $872 Million
Labcorp said it will pay $722 million in cash, with up to $150 million more tied to revenue from a prostate cancer test.
MNA | Oct 15, 2026, 12:14 PM UTC
M
Labcorp Agrees to Acquire BioReference Health Assets for $722 Million
Labcorp agreed to acquire select assets of BioReference Health, a subsidiary of OPKO Health, for $722 million in cash at closing.
EQUITY | Oct 15, 2026, 12:08 PM UTC
M
Labcorp Agrees to Acquire Select BioReference Health Assets
Labcorp entered into an agreement with OPKO Health to acquire select assets of BioReference Health.
EQUITY | Oct 15, 2026, 11:34 AM UTC
M
Labcorp Transaction Purchase Price Is $722 Million in Cash
MNA | Oct 15, 2026, 11:34 AM UTC
L
OPK: Transitioning to a therapeutics-focused model with unique multi-specific assets and strong partnerships
The company is shifting from diagnostics to therapeutics, highlighted by ModeX’s multi-specific antibody platform and a robust clinical pipeline. Strategic collaborations with Merck and Regeneron, strong capital position
EQUITY | Sep 10, 2026, 02:49 PM UTC
L
OPK: Transitioning to a therapeutics-focused model with innovative multi-specific assets and strong partnerships
The company is shifting from diagnostics to therapeutics, highlighted by ModeX's unique multi-specific antibody platform and a robust pipeline in oncology, immunology, and infectious diseases. Strategic collaborations, s
EQUITY | Sep 10, 2026, 02:32 PM UTC
L
OPKO Health to participate in Wells Fargo 21st Annual Healthcare Conference
OPKO Health said Elias A. Zerhouni, M.D., President and Vice Chairman, and Adam… will participate in the Wells Fargo 21st Annual Healthcare Conference.
EQUITY | Sep 08, 2026, 05:57 PM UTC
L
OPK - OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
OPK - OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
EQUITY | Sep 08, 2026, 05:55 PM UTC
H
OPKO Health expands deal with HealthCare Royalty via $125M notes
OPKO Health expands its strategic relationship with HealthCare Royalty through a $125 million notes issuance secured by Mazdutide royalty interests.
MNA | Aug 13, 2026, 01:15 PM UTC
H
Crude Oil Down Over 5%; Boeing Shares Rise After Q2 Results
U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining more than 1% on Tuesday. The Dow traded up 1.25% to 52,860.91 while the NASDAQ slipped 0.01% to 24,928.70. The S&P 500 also rose,
MACRO | Jul 28, 2026, 04:28 PM UTC
H
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Tuesday. Shares of Sherwin-Williams Co (NYSE: SHW ) rose sharply after the company reported better-than-expected second-quarter financial resu
EARNINGS | Jul 28, 2026, 02:05 PM UTC
H
among early movers from the earnings calendar last night gainers OPK +5.7%, HAPN +5.4%, WELL +3.9%, APLD +3.8%, CDNS +3.8%, RNGR +1.9%, AGYS
among early movers from the earnings calendar last night gainers OPK +5.7%, HAPN +5.4%, WELL +3.9%, APLD +3.8%, CDNS +3.8%, RNGR +1.9%, AGYS +1.7%, ESI +1.6%, SSD +1.5%, CDP +1.3%, SUI +1.0%, NUE +0.9%, PFG +0.2%, BRX +0
EARNINGS | Jul 28, 2026, 12:57 PM UTC
L
Opko Health sees Q3 revenue $131M-$142M, consensus $134.65M
Sees Q3 total costs and...
EARNINGS | Jul 27, 2026, 08:47 PM UTC
L
Opko Health reports Q2 EPS (1c), one estimate (11c)
Reports Q2 revenue...
EARNINGS | Jul 27, 2026, 08:45 PM UTC
L
OPK +17%, CSBR +8.2%, HAPN +7.1%, AMKR +4.4%, CDNS +3.8%, WELL +3.5%, APLD +3.1%, FFIV +1.7% after results
OPK +17%, CSBR +8.2%, HAPN +7.1%, AMKR +4.4%, CDNS +3.8%, WELL +3.5%, APLD +3.1%, FFIV +1.7% after results
EQUITY | Jul 27, 2026, 08:21 PM UTC
L
NWBI: EPS $0.37, beat by $0.03 - Rev Beat TFII: EPS $1.85, beat by $0.26 - Rev Beat - Rev $2.29B.. Expected $2.22B OPK: EP
NWBI: EPS $0.37, beat by $0.03 - Rev Beat TFII: EPS $1.85, beat by $0.26 - Rev Beat - Rev $2.29B.. Expected $2.22B OPK: EPS -$0.01, beat by $0.07 - Rev Beat
EQUITY | Jul 27, 2026, 08:14 PM UTC
H
OPK Opko Health RESULTS: Q2, Q2 EPS $-0.01, Opko Health Earnings Notes:, Consolidated total REVs for the second quarter of 2026 were $163.5M
OPK Opko Health RESULTS: Q2, Q2 EPS $-0.01, Opko Health Earnings Notes:, Consolidated total REVs for the second quarter of 2026 were $163.5M
RATES | Jul 27, 2026, 08:11 PM UTC
H
OPKO Health Raises FY2026 Sales Guidance from $530.000M-$560.000M to $560.000M-$585.000M vs $534.899M Est
OPKO Health (NASDAQ: OPK ) raises FY2026 sales outlook from $530.000 million-$560.000 million to $560.000 million-$585.000 million vs $534.899 million estimate.
EARNINGS | Jul 27, 2026, 08:07 PM UTC
L
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Seer (NASDAQ: SEER ) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals (NASDAQ: UPC ) stock m
EQUITY | Jul 02, 2026, 09:05 PM UTC